Advanced search×

Nesfatin-1 - Role as possible new potent regulator of food intake

Regul Pept 163(1-3):6 (2010) PMID 20580651

Nesfatin-1 is an 82 amino acid peptide recently discovered in the brain which is derived from nucleobindin2 (NUCB2), a protein that is highly conserved across mammalian species. Nesfatin-1 has received much attention over the past two years due to its reproducible food intake-reducing effect that is linked with recruitment of other hypothalamic peptides regulating feeding behavior. A growing amount of evidence also supports that various stressors activate fore- and hindbrain NUCB2/nesfatin-1 circuitries. In this review, we outline the central nervous system distribution of NUCB2/nesfatin-1, and recent developments on the peripheral expression of NUCB2/nesfatin-1, in particular its co-localization with ghrelin in gastric X/A-like cells and insulin in sz-cells of the endocrine pancreas. Functional studies related to the characteristics of nesfatin-1's inhibitory effects on dark phase food intake are detailed as well as the central activation of NUCB2/nesfatin-1 immunopositive neurons in the response to psychological, immune and visceral stressors. Lastly, potential clinical implications of targeting NUCB2/nesfatin-1 signaling and existing gaps in knowledge to ascertain the role and mechanisms of action of nesfatin-1 are presented.

Copyright © 2010 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.regpep.2010.05.002
Version: za2963e q8zac q8zb7 q8zce q8zde q8ze7 q8zfd q8zg5

Similar articles you may find interesting…

  1. Glucagon-like peptide-2, but not glucose-dependent insulinotropic polypeptide, stimulates glucagon release in patients with type 1 diabetes

    Regul Pept 163(1-3):6 (2010) PMID 20580750

    This study investigated the glucagon-releasing properties of the hormones glucagon-like peptide-2 (GLP-2) and glucose-dependent insulinotropic polypeptide (GIP) in 8 patients with type 1 diabetes mellitus (T1DM) without paracrine intraislet influence of insulin (C-peptide negative following a 5 g in...
  2. Sleep and the metabolic syndrome.

    Exp Physiol 92(1):67-78 (2007) PMID 17085678

    The metabolic syndrome represents a clustering of several interrelated risk factors of metabolic origin that are thought to increase cardiovascular risk. It is still uncertain whether this clustering results from multiple underlying risk factors or whether it has a single cause. One metabolic abnorm...
  3. Effects of leptin replacement on hypothalamic-pituitary growth hormone axis function and circulating ghrelin levels in ob/ob mice.

    Am J Physiol Endocrinol Metab 292(3):E891-9 (2007) PMID 17122091

    These results demonstrate that leptin replacement has positive effects on multiple levels of GH axis function in ob/ob mice....